Improved assay for R(-)-apomorphine with application to clinical pharmacokinetic studies in Parkinson's disease |
| |
Authors: | Ingram Wendy M Priston Melanie J Sewell Graham J |
| |
Affiliation: | Department of Pharmacy, Derriford Hospital, Plymouth PL6 8DH, UK. wendy.ingram@pms.ac.uk |
| |
Abstract: | A high performance liquid chromatographic assay for the quantitative determination of apomorphine in human plasma is described. Sample clean-up and concentration was optimised using solid-phase extraction on C18 cartridges, enabling rapid and sensitive determination of apomorphine and potential metabolites. The limit of apomorphine quantification, using fluorescence detection, was 0.5 ng/mL. The assay was stability-indicating, and allowed the detection of analytes in the presence of commonly co-administered anti-Parkinsonian drugs. Apomorphine was stable in frozen plasma containing 0.14% (w/v) ascorbic acid for 98 days, and through four freeze-thaw cycles. The assay has been used in clinical pharmacokinetic studies of apomorphine in patients with Parkinson's disease, and in preliminary studies of novel apomorphine delivery devices in volunteers. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|